| Financial Year |
March 31 2023 |
| Monetary Funds |
415,219,636.94 |
| Held-for-trading Financial Assets |
50,072,328.77 |
| Notes Receivable |
42,869,459.76 |
| Accounts Receivable |
171,167,499.26 |
| Advances to Suppliers |
5,626,213.38 |
| Other Receivables |
25,617,729.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
341,439,825.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,349,856.35 |
| Total Current Assets |
1,095,174,012.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
222,491,992.25 |
| Under-construction Projects |
26,508,335.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,554,573.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,072,446.39 |
| Deferred Income Tax Assets |
8,423,972.55 |
| Other Non-Current Assets |
24,244,988.62 |
| Sub-Total of Non-Current Assets |
370,758,669.39 |
| Total Assets |
1,465,932,682.14 |
| Short-Term Loans |
28,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,280,642.25 |
| Accounts Payable |
69,250,437.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,002,837.51 |
| Taxes Payable |
1,897,866.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,743,449.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
235,194.27 |
| Other Current Liabilities |
1,712,426.66 |
| Sub-Total of Current Liabilities |
267,730,993.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,415,050.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,579,779.68 |
| Total Liabilities |
292,310,772.94 |
| Paid-In Capital(Or Share Stock) |
72,758,822.00 |
| Capital Surplus |
616,918,112.59 |
| Surplus Reserve |
51,319,139.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
423,094,025.17 |
| Minority Stockholder's Interest |
9,519,298.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,164,102,610.60 |
| Owner's Equity（Stockholder's Equity） |
1,173,621,909.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,465,932,682.14 |
